ergolines - CISMeF

Preferred Label : ergolines;

MeSH definition : A series of structurally-related alkaloids that contain the ergoline backbone structure.;

MeSH hyponym : ergoline;

MeSH Related Number : ergoline; 478-88-6;

Related CAS MeSH : 478-88-6 (Ergoline);

Wikipedia link : https://en.wikipedia.org/wiki/Ergoline;

Is substance : O;

Details

Origin ID

D004873;

UMLS CUI

C0014699;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
CISMeF manual mappings
- Ergoline derivative (substance) [SNOMED CT concept]
Record concept(s)
- ergoline [MeSH concept]
- ergolines [MeSH concept]
Related MeSH Supplementary Concept(s)
- (5R,8R,10R)-6-methyl-8-(1,2,4-triazol-1-ylmethyl)ergoline [MeSH Supplementary Concept]
- 1,2,3,4,5,6-hexa(6-methyl-8-(diethylcarbamoylamino)-ergoline-1-yl-methyl) [MeSH Supplementary Concept]
- 1-(8-(hydroxymethyl)-1-(2-(2-methylpyrrolidin-1-yl)ethyl)-4,4a,7,8,9,9a-hexahydroindolo(1,14-fg)quinolin-6(1H)-yl)ethanone [MeSH Supplementary Concept]
- 1-bromo-2,2-di(6-methyl-methyl-8-(diethylcarbamoylamino)-ergoline-1-yl-methyl)-3-(6-methyl-8-(diethylcarbamoylamino)-ergoline-1-yl)propane [MeSH Supplementary Concept]
- 1-methoxyagroclavine [MeSH Supplementary Concept]
- 2,3-dihydrolysergine [MeSH Supplementary Concept]
- 3,12-dihydroroquefortine [MeSH Supplementary Concept]
- 4-((2-(cyclohexylcarbamoyl)ethyl)methylamino)-1-isopropyl-1,3,4,5-tetrahydrobenz(cd)indole [MeSH Supplementary Concept]
- 4-(9,10-didehydroergolin-8-yl)methylpiperazine-2,6-dione [MeSH Supplementary Concept]
- 4-hydroxyamesergide [MeSH Supplementary Concept]
- 6-ethyl-9-oxaergoline [MeSH Supplementary Concept]
- 6-methyl-8 alpha-N-methylsulfamoylaminoergoline [MeSH Supplementary Concept]
- 6-methyl-8 beta-ergoline acetonitrile [MeSH Supplementary Concept]
- 6-propyl-8-ergolinylacetamide [MeSH Supplementary Concept]
- 8-((4-(4-methoxyphenyl)-1-piperazinyl)methyl)-6-methylergoline [MeSH Supplementary Concept]
- 9,10-ergolene [MeSH Supplementary Concept]
- BAM 1120 [MeSH Supplementary Concept]
- CF 25397 [MeSH Supplementary Concept]
- CH 29717 [MeSH Supplementary Concept]
- CK 204-933 [MeSH Supplementary Concept]
- CM 29-712 [MeSH Supplementary Concept]
- CQA 206-291 [MeSH Supplementary Concept]
- CQP 201-403 [MeSH Supplementary Concept]
- D-6-methyl-8-ergolin-1-ylacetic acid amide tartrate [MeSH Supplementary Concept]
- FCE 22716 [MeSH Supplementary Concept]
- FCE 23884 [MeSH Supplementary Concept]
- FCE 24220 [MeSH Supplementary Concept]
- FCE 24379 [MeSH Supplementary Concept]
- GYKI 32887 [MeSH Supplementary Concept]
- LY 178210 [MeSH Supplementary Concept]
- LY 53857 [MeSH Supplementary Concept]
- N-(2,6-dimethylergoline-8-yl)-2,2-dimethylpropanamide [MeSH Supplementary Concept]
- N-(2-chloro-6-methylergoline-8-yl)-2,2-dimethylpropanamide [MeSH Supplementary Concept]
- N-(8'-hydroxy-2'-methyl-5'-(2-methylpropyl)-3',6'-dioxo-7'-(phenylmethyl)oxazolidino(2,3-c)piperazin-2'-yl) 6-methylergoline-8-carboxamide [MeSH Supplementary Concept]
- N-desmethyl lergotrile [MeSH Supplementary Concept]
- N-propyl-9-oxaergoline [MeSH Supplementary Concept]
- RU 41656 [MeSH Supplementary Concept]
- SDZ MAR 327 [MeSH Supplementary Concept]
- agroclavine [MeSH Supplementary Concept]
- amesergide [MeSH Supplementary Concept]
- chanoclavine [MeSH Supplementary Concept]
- cianergoline [MeSH Supplementary Concept]
- costaclavin [MeSH Supplementary Concept]
- elymoclavine [MeSH Supplementary Concept]
- epoxyagroclavine-1 [MeSH Supplementary Concept]
- ergocornine [MeSH Supplementary Concept]
- ergocristine [MeSH Supplementary Concept]
- ergocryptine [MeSH Supplementary Concept]
- ergotoxine [MeSH Supplementary Concept]
- etisulergine [MeSH Supplementary Concept]
- isofumigaclavine A [MeSH Supplementary Concept]
- isofumigaclavine B [MeSH Supplementary Concept]
- lergotrile [MeSH Supplementary Concept]
- lergotrile mesylate [MeSH Supplementary Concept]
- lumelysergol [MeSH Supplementary Concept]
- lysergol [MeSH Supplementary Concept]
- mergocriptine [MeSH Supplementary Concept]
- mesulergine [MeSH Supplementary Concept]
- paliclavine [MeSH Supplementary Concept]
- proterguride [MeSH Supplementary Concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients